281 related articles for article (PubMed ID: 22028477)
21. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Wierda WG; Byrd JC; Abramson JS; Bhat S; Bociek G; Brander D; Brown J; Chanan-Khan A; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lancet J; Ma S; Malek S; Mosse C; Shadman M; Siddiqi T; Stephens D; Wagner N; Zelenetz AD; Dwyer MA; Sundar H
J Natl Compr Canc Netw; 2017 Nov; 15(11):1414-1427. PubMed ID: 29118233
[TBL] [Abstract][Full Text] [Related]
22. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
[TBL] [Abstract][Full Text] [Related]
23. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
[TBL] [Abstract][Full Text] [Related]
24. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.
Blombery PA; Wong SQ; Hewitt CA; Dobrovic A; Maxwell EL; Juneja S; Grigoriadis G; Westerman DA
Haematologica; 2012 May; 97(5):780-3. PubMed ID: 22133769
[TBL] [Abstract][Full Text] [Related]
25. High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies.
Boyd EM; Bench AJ; van 't Veer MB; Wright P; Bloxham DM; Follows GA; Scott MA
Br J Haematol; 2011 Dec; 155(5):609-12. PubMed ID: 21910720
[TBL] [Abstract][Full Text] [Related]
26. Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.
Itamura H; Ide M; Sato A; Sueoka-Aragane N; Sueoka E; Nishida A; Masunari T; Aoki S; Takizawa J; Suzumiya J; Kimura S
Int J Hematol; 2018 Oct; 108(4):416-422. PubMed ID: 30043333
[TBL] [Abstract][Full Text] [Related]
27. [Novelties in the diagnostics and therapy of hairy cell leukemia].
Sári E; Rajnai H; Dénes K; Bödör C; Csomor J; Körösmezey G; Tárkányi I; Eid H; Nagy Z; Demeter J
Magy Onkol; 2016 Jun; 60(2):137-44. PubMed ID: 27275640
[TBL] [Abstract][Full Text] [Related]
28. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
Maitre E; Cornet E; Troussard X
Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
[TBL] [Abstract][Full Text] [Related]
29. Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections.
Warden DW; Ondrejka S; Lin J; Durkin L; Bodo J; Hsi ED
Am J Surg Pathol; 2013 Feb; 37(2):305-8. PubMed ID: 23211289
[TBL] [Abstract][Full Text] [Related]
30. Hairy cell leukaemia with unusual BRAF mutations.
Maitre E; Macro M; Troussard X
J Cell Mol Med; 2023 Sep; 27(17):2626-2630. PubMed ID: 37530550
[TBL] [Abstract][Full Text] [Related]
31. Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing.
Vacca D; Cancila V; Gulino A; Lo Bosco G; Belmonte B; Di Napoli A; Florena AM; Tripodo C; Arancio W
Mol Biol Rep; 2018 Feb; 45(1):1-7. PubMed ID: 29238890
[TBL] [Abstract][Full Text] [Related]
32. Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemia.
Rider T; Powell R; Gover R; Ansell R; Bastow S; Ghurye RR; Stewart H; Chevassut T
Hematol Oncol; 2014 Sep; 32(3):158-61. PubMed ID: 24123063
[No Abstract] [Full Text] [Related]
33. [Molecular and therapeutic advances in Hairy cell leukemia].
Balsat M; Cornillon J
Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
[TBL] [Abstract][Full Text] [Related]
34. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Maître E; Cornet E
Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma.
Suzuki T; Miyoshi H; Shimono J; Kawamoto K; Arakawa F; Furuta T; Yamada K; Yanagida E; Takeuchi M; Seto M; Sone H; Takizawa J; Ohshima K
Pathol Int; 2020 May; 70(5):280-286. PubMed ID: 32052529
[TBL] [Abstract][Full Text] [Related]
36. BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens.
Thomas C; Amanuel B; Finlayson J; Grieu-Iacopetta F; Spagnolo DV; Erber WN
Pathology; 2015 Jun; 47(4):349-54. PubMed ID: 25938346
[TBL] [Abstract][Full Text] [Related]
37. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
[TBL] [Abstract][Full Text] [Related]
38. Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment.
Polderdijk MCE; Heron M; Kuipers S; Rijkers GT
Expert Rev Clin Immunol; 2019 Aug; 15(8):857-867. PubMed ID: 31282776
[No Abstract] [Full Text] [Related]
39. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
Xi L; Arons E; Navarro W; Calvo KR; Stetler-Stevenson M; Raffeld M; Kreitman RJ
Blood; 2012 Apr; 119(14):3330-2. PubMed ID: 22210875
[TBL] [Abstract][Full Text] [Related]
40. Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity.
Traverse-Glehen A; Baseggio L; Salles G; Coiffier B; Felman P; Berger F
Discov Med; 2012 Apr; 13(71):253-65. PubMed ID: 22541613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
